Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine ; volume:11 ; number:1 ; day:27 ; month:3 ; year:2012 ; pages:1-4 ; date:12.2012
Malaria journal ; 11, Heft 1 (27.3.2012), 1-4, 12.2012
- Urheber
-
Corpolongo, Angela
- Beteiligte Personen und Organisationen
-
De Nardo, Pasquale
Ghirga, Piero
Gentilotti, Elisa
Bellagamba, Rita
Tommasi, Chiara
Paglia, Maria Grazia
Nicastri, Emanuele
Narciso, Pasquale
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-11-91
- URN
-
urn:nbn:de:1111-2016080631677
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Corpolongo, Angela
- De Nardo, Pasquale
- Ghirga, Piero
- Gentilotti, Elisa
- Bellagamba, Rita
- Tommasi, Chiara
- Paglia, Maria Grazia
- Nicastri, Emanuele
- Narciso, Pasquale
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy
Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy
Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?
Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine
Development of a dissolution method for lumefantrine and artemether in immediate release fixed dose artemether/lumefantrine tablets
The clinical efficacy of artemether/lumefantrine (Coartem®)
Outcome of artemether-lumefantrine treatment for uncomplicated malaria in HIV-infected adult patients on anti-retroviral therapy
Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine
Safety and tolerability of artemether-lumefantrine versus dihydroartemisinin-piperaquine for malaria in young HIV-infected and uninfected children
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study
Artemether-lumefantrine efficacy among adults on antiretroviral therapy in Malawi
Malaria case-management under artemether-lumefantrine treatment policy in Uganda
Does artemether–lumefantrine administration affect mosquito olfactory behaviour and fitness?